Filing Details

Accession Number:
0001072613-10-000201
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-02-11 12:00:00
Reporting Period:
2007-02-23
Filing Date:
2010-02-11
Accepted Time:
2010-02-11 17:25:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
19520 Chattem Inc CHTT Pharmaceutical Preparations (2834) 620156300
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236873 W Bill Stacy Williams Island Ferry Rd
Chattanooga TN 37404
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2007-02-23 350 $55.71 14,109 No 4 P Direct
Common Stock Disposition 2010-02-09 14,081 $93.50 28 No 4 U Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 U Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock 1999 Stock Option (right to buy) $37.06 2016-04-12 1,000 1,000 Direct
Common Stock 1999 Stock Option (right to buy) $43.78 2015-04-13 500 500 Direct
Common Stock 1999 Stock Option (right to buy) $59.73 2017-04-11 2,000 2,000 Direct
Common Stock 1999 Stock Option (right to buy) $70.35 2018-04-09 2,000 2,000 Direct
Common Stock 1999 Stock Option (right to buy) $52.37 2019-04-08 2,000 2,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2016-04-12 1,000 1,000 Direct
2015-04-13 500 500 Direct
2017-04-11 2,000 2,000 Direct
2018-04-09 2,000 2,000 Direct
2019-04-08 2,000 2,000 Direct
Footnotes
  1. Reflects total beneficial ownership on February 9, 2010, which includes the 350 shares acquired on February 23, 2007. All Form 4s filed on behalf of the reporting person after February 23, 2007 and prior to the date of this filing are hereby amended to include these previously unreported shares.
  2. The options became fully vested and exercisable in accordance with their terms on February 9, 2010, upon the consummation of the tender offer commenced by River Acquisition Corp., an indirect wholly-owned subsidiary of sanofi-aventis, for all outstanding shares of common stock of Chattem, Inc. at $93.50 per share, net to the sellers in cash without interest, less any required withholding taxes.